Item 16. FORM 10-K SUMMARY

3K characters. Original on sec.gov · Markdown

Item 16. FORM 10-K SUMMARY

None.


111			\| 2025 Form 10-K

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, AbbVie Inc. has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


AbbVie Inc.
By:	/s/ ROBERT A. MICHAEL
	Name:	Robert A. Michael
	Title:	Chairman of the Board and Chief Executive Officer
Date:	February 20, 2026

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of AbbVie Inc. on February 20, 2026 in the capacities indicated below.


/s/ ROBERT A. MICHAEL						/s/ SCOTT T. REENTS
Robert A. Michael Chairman of the Board and Chief Executive Officer (Principal Executive Officer)						Scott T. Reents Executive Vice President, Chief Financial Officer (Principal Financial Officer)

/s/ DAVID R. PURDUE						/s/ ROBERT J. ALPERN, M.D.
David R. Purdue Senior Vice President, Controller (Principal Accounting Officer)						Robert J. Alpern, M.D. Director of AbbVie Inc.

/s/ ROXANNE S. AUSTIN						/s/ WILLIAM H.L. BURNSIDE
Roxanne S. Austin Director of AbbVie Inc.						William H.L. Burnside Director of AbbVie Inc.

/s/ JENNIFER L. DAVIS						/s/ THOMAS J. FALK
Jennifer L. Davis Director of AbbVie Inc.						Thomas J. Falk Director of AbbVie Inc.

/s/ THOMAS C. FREYMAN						/s/ BRETT J. HART
Thomas C. Freyman Director of AbbVie Inc.						Brett J. Hart Director of AbbVie Inc.

/s/ MELODY B. MEYER						/s/ SUSAN E. QUAGGIN, M.D.
Melody B. Meyer Director of AbbVie Inc.						Susan E. Quaggin, M.D. Director of AbbVie Inc.

/s/ EDWARD J. RAPP						/s/ REBECCA B. ROBERTS
Edward J. Rapp Director of AbbVie Inc.						Rebecca B. Roberts Director of AbbVie Inc.

/s/ FREDERICK H. WADDELL
Frederick H. Waddell Director of AbbVie Inc.


						2025 Form 10-K \|			112

Previous: Item 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES